» Articles » PMID: 10632249

Parents' Utilities for Outcomes of Occult Bacteremia

Overview
Specialty Pediatrics
Date 2000 Jan 13
PMID 10632249
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe parents' values for outcomes of occult bacteremia using utility assessment, a quantitative method that incorporates risk preference.

Design: Computer-based utility assessment interview.

Setting: Urban children's hospital pediatric emergency department with 50 000 visits annually.

Participants: Convenience sample of parents presenting with a child between 3 and 36 months.

Main Outcome Measure: Parents' utility values for 8 outcomes from treatment of occult bacteremia: blood drawing, localized infection, hospitalization for antibiotics, meningitis with recovery, meningitis resulting in deafness, minor brain damage, severe brain damage, and death.

Results: Ninety-four subjects successfully completed the interview. Mean utilities were 0.9974 for blood drawing, 0.9941 for local infection, 0.9921 for hospitalization, 0.9768 for meningitis with recovery, 0.8611 for deafness, 0.7393 for minor brain damage, 0.3903 for severe brain damage, and 0.0177 for death. All values were significantly different from those that immediately preceded and succeeded (P<.0001), except for local infection vs hospitalization (P = .14). Median utilities for blood drawn, local infection, and hospitalization were 1. There were no significant differences among utilities of parents who presented with a febrile child (temperature > or =39 degrees C), or an afebrile child (temperature <39 degrees C). There were also no significant differences among utilities regardless of whether parents had children with prior experience with the outcomes.

Conclusions: Assessment of utilities for outcomes of occult bacteremia yielded extremely high mean and median values for outcomes without permanent sequelae. This suggests that parents presenting to an emergency department may rationally prefer painful transient experiences, including venipuncture, for their children rather than risk even rare chances of severe outcomes.

Citing Articles

Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.

Shen J, Ji C, Luo X, Hu Y PLoS One. 2024; 19(9):e0310274.

PMID: 39250492 PMC: 11383224. DOI: 10.1371/journal.pone.0310274.


Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France.

de Pouvourville G, Breau-Brunel M, Loncle-Provot V, Beck E, Gaugain L, Nachbaur G Pharmacoecon Open. 2024; 8(4):539-557.

PMID: 38780884 PMC: 11252096. DOI: 10.1007/s41669-024-00488-5.


Ignored and undervalued in public health: a systematic review of health state utility values associated with syphilis infection.

Miao P, Terris-Prestholt F, Fairley C, Tucker J, Wiseman V, Mayaud P Health Qual Life Outcomes. 2024; 22(1):17.

PMID: 38350925 PMC: 10863090. DOI: 10.1186/s12955-024-02234-1.


Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China.

Zhang H, Zhang H, Fang H Hum Vaccin Immunother. 2024; 20(1):2313872.

PMID: 38348600 PMC: 10865926. DOI: 10.1080/21645515.2024.2313872.


Lifecycle model-based evaluation of infant 4CMenB vaccination in the UK.

Sevilla J, Tortorice D, Kantor D, Regan J, Meszaros K, Beck E Eur J Health Econ. 2024; 25(7):1133-1146.

PMID: 38182698 PMC: 11377635. DOI: 10.1007/s10198-023-01654-y.